登入選單
返回Google圖書搜尋
Pharmacoepidemiology - Volume 1, Contains Papers from the 3rd International Conference on Pharmacoepidemiology, Minneapolis, MN, September 9-11 1987
註釋Pharmacoepidemiology and Public Policy; Risk Assessment of New Drugs, Pharmacoepidemiology and Regulatory Decisionmaking; Industry Perspectives and the Contributions of Pharmacoepidemiology to Public Health; Impact of Drug Products Liability on Needs for Pharmacoepidemiology Studies and Expertise; Epidemiology in the Courtroom, Anatomy of an Intellectual Embarrassment; A Brief Review of the Yellow Card Adverse Reaction Reporting Scheme in the United Kingdom; Frequency Analysis of Spontaneous Reports from Different Countries, The Example of Continental Western Europe; Evaluation of First Year Experience of a State Pilot to Promote Physician Reporting of Adverse Drug Events to the Food and Drug Administration; Monitoring System for Adverse Events Following Immunization Risk Factors for Convulsions After Vaccination; Application of a New Method for Adverse Experience Monitoring to Premarketing Studies on Two New Drugs, Some Experiences; A Nationwide Drug Surveillance Network; The Pharmacoepidemiology Data Base of the Brigham and Women's Hospital; Overcoming Limitations of Routine Surveillance of Drug Overdose; Current Status of the Saskatchewan Prescription Drug Plan; Early Experience with the COMPASS Data Base; Postmarketing Surveillance in Tayside, A Further Assessment of Record Linkage Using Five Nonsteroidal Anti-inflammatory Drugs; Nonsteroidal Antiinflammatory Drugs and Upper Gastrointestinal Bleeding; Impact of Nonsteroidal Antiinflammatory Agents on General Gastrointestinal Upset in an Elderly Population; NSAIDS as a Cause of Morbidity and Mortality from Peptic Ulcer Complications in New South Wales; The Relationship Between Rheumatoid Arthritis and Risk of Cancer, Controlling from the Effect of Drugs, in Hospitalized Patients of Saskatchewan, Canada; Collaborative Study of the Effects of Acyclovir in Pregnancy; Creutzfeldt-Jakob Disease, Human Growth Hormone, and Its Replacement with Synthetic Growth Hormone; Retrovir, The Challenge of Postmarketing Surveillance; Differences in Psychotropic Medications Reported Used by Blacks and Whites; The Dunedin Program, A Longitudinal Study of Aging; Psychotropic Drug Use and Health Outcomes in Nursing Homes; What is the Cost of Nephrotoxicity Associated with Aminoglycosides.